News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
260,961 Results
Type
Article (13571)
Company Profile (110)
Press Release (247280)
Section
Business (87997)
Career Advice (461)
Deals (15329)
Drug Delivery (64)
Drug Development (36533)
Employer Resources (49)
FDA (6279)
Job Trends (6183)
News (150115)
Policy (14015)
Tag
Academia (435)
Alliances (23085)
Alzheimer's disease (347)
Approvals (6270)
Artificial intelligence (59)
Bankruptcy (143)
Best Places to Work (4313)
Biosimilars (39)
Biotechnology (44)
Breast cancer (42)
Cancer (293)
Career advice (405)
Cell therapy (41)
Clinical research (30350)
Collaboration (134)
Compensation (57)
COVID-19 (746)
C-suite (49)
Data (298)
Diabetes (50)
Diagnostics (1232)
Drug pricing (57)
Earnings (31509)
Employer resources (43)
Events (36665)
Executive appointments (152)
FDA (6444)
Funding (92)
Gene therapy (58)
GLP-1 (290)
Government (1265)
Healthcare (3539)
Infectious disease (763)
Inflammatory bowel disease (45)
Interviews (58)
IPO (5814)
Job creations (2049)
Job search strategy (372)
Layoffs (166)
Legal (3413)
Lung cancer (44)
Manufacturing (85)
Medical device (1263)
Medtech (1265)
Mergers & acquisitions (9538)
Metabolic disorders (158)
Neuroscience (439)
NextGen Class of 2024 (1580)
Non-profit (589)
Northern California (401)
Obesity (96)
Opinion (109)
Patents (51)
People (28422)
Pharmaceutical (64)
Phase I (7891)
Phase II (12829)
Phase III (11541)
Pipeline (137)
Podcasts (39)
Policy (44)
Postmarket research (1399)
Preclinical (3162)
Radiopharmaceuticals (116)
Rare diseases (83)
Real estate (2629)
Regulatory (9810)
Research institute (562)
Resumes & cover letters (55)
Southern California (405)
Startups (1624)
United States (3962)
Vaccines (110)
Weight loss (77)
Date
Today (41)
Last 7 days (298)
Last 30 days (1095)
Last 365 days (12659)
2024 (11198)
2023 (14261)
2022 (19567)
2021 (20074)
2020 (19040)
2019 (14887)
2018 (11714)
2017 (13890)
2016 (13134)
2015 (15475)
2014 (12420)
2013 (10596)
2012 (11402)
2011 (11928)
2010 (10895)
Location
Africa (312)
Arizona (39)
Asia (19760)
Australia (2553)
California (931)
Canada (575)
China (106)
Colorado (38)
Connecticut (38)
Europe (38714)
Florida (131)
Illinois (105)
Indiana (82)
Kansas (51)
Maryland (146)
Massachusetts (814)
Minnesota (52)
New Jersey (390)
New York (255)
North Carolina (269)
Northern California (401)
Pennsylvania (266)
South America (498)
Southern California (405)
Texas (123)
Washington State (66)
260,961 Results for "tigris pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Spectral Medical Provides October Tigris Trial Update
November 5, 2024
·
3 min read
Spectral Medical Provides April 2024 Tigris Trial Update
Spectral Medical Inc., a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, provided an update on the Company’s Tigris trial, a Phase 3 follow-on study evaluating the use of Polymyxin B Hemoperfusion in a randomized controlled trial of adults treated for endotoxemia and septic shock.
May 6, 2024
·
3 min read
Press Releases
Spectral Medical Provides August Tigris Trial Update
September 3, 2024
·
4 min read
Press Releases
Spectral Medical Provides July Tigris Trial Update
August 1, 2024
·
3 min read
Drug Development
Spectral Medical Provides Tigris Trial Update - April 10, 2024
Spectral Medical Inc., a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, provided an update on the Company’s Tigris trial, a Phase 3 follow-on study evaluating the use of Polymyxin B Hemoperfusion in a randomized controlled trial of adults treated for endotoxemia and septic shock.
April 10, 2024
·
3 min read
Drug Development
Spectral Medical Provides February Tigris Trial Update
Spectral Medical Inc. today provided an update on the Company’s Tigris trial, a Phase 3 follow-on study evaluating the use of Polymyxin B Hemoperfusion (“PMX”) in a randomized controlled trial of adults treated for endotoxemia and septic shock.
February 28, 2024
·
3 min read
Drug Development
Spectral Medical Provides January Tigris Trial Update
Spectral Medical Inc. today provided an update on the Company’s Tigris trial, a Phase 3 follow-on study evaluating the use of Polymyxin B Hemoperfusion (“PMX”) in a randomized controlled trial of adults treated for endotoxemia and septic shock.
January 30, 2024
·
3 min read
Drug Development
Spectral Medical Provides Early February Tigris Trial Update
Spectral Medical Inc today provided an update on the Company’s Tigris trial, a Phase 3 follow-on study evaluating the use of Polymyxin B Hemoperfusion (“PMX”) in a randomized controlled trial of adults treated for endotoxemia and septic shock.
February 5, 2024
·
4 min read
Drug Development
Spectral Medical Provides June 2024 Tigris Trial Update
July 3, 2024
·
3 min read
Drug Development
Spectral Medical Provides November Tigris Trial Update
Spectral Medical Inc. today provided an update for the month of November on the Company’s Tigris trial, a Phase 3 follow-on study evaluating the use of Polymyxin B Hemoperfusion (“PMX”) in a randomized controlled trial of adults treated for endotoxemia and septic shock.
December 4, 2023
·
4 min read
1 of 26,097
Next
